MagVenture, a company out of Farum, Denmark, won FDA clearance for its MagVita transcranial magnetic stimulation (TMS) therapy system to be used in the U.S. to treat major depressive disorder in patients who failed to respond to other therapies. In 2011, the device was the first TMS system approved in the European Union.

Discover The World's MOST COMPREHENSIVE Mental Health Assessment Platform

Efficiently assess your patients for 80+ possible conditions with a single dynamic, intuitive mental health assessment. As low as $12 per patient per year.

Features of the system according to the product page:

It can perform repetitive Transcranial Magnetic Stimulation (rTMS) and run many protocols successively (up to 20.000 pulses).

  • Depression protocol pre-defined.
  • 30 pps maximum rep. rate.
  • Chair and vacuum pillow for patient comfort.
  • Super flexible arm to hold coil.
  • Built-in computer with user-friendly software.
  • Quick protocol set-up and storage.
  • Accessories included for treatment consistency and easy use.

Hot daily news right into your inbox.